Medibank Private Limited
MDBPF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $8,546 | $8,018 | $7,499 | $7,092 |
| % Growth | 6.6% | 6.9% | 5.7% | – |
| Cost of Goods Sold | $6,655 | $6,289 | $5,860 | $5,680 |
| Gross Profit | $1,891 | $1,729 | $1,640 | $1,413 |
| % Margin | 22.1% | 21.6% | 21.9% | 19.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $879 | $755 | $671 | $666 |
| SG&A Expenses | $1,055 | $927 | $787 | $752 |
| Sales & Mktg Exp. | $176 | $172 | $116 | $86 |
| Other Operating Expenses | $108 | $91 | $126 | $101 |
| Operating Expenses | $1,163 | $1,017 | $913 | $853 |
| Operating Income | $729 | $712 | $727 | $560 |
| % Margin | 8.5% | 8.9% | 9.7% | 7.9% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $729 | $712 | $727 | $560 |
| Tax Expense | $220 | $215 | $216 | $166 |
| Net Income | $501 | $493 | $511 | $394 |
| % Margin | 5.9% | 6.1% | 6.8% | 5.6% |
| EPS | 0.18 | 0.18 | 0.19 | 0.14 |
| % Growth | 0% | -5.3% | 35.7% | – |
| EPS Diluted | 0.18 | 0.18 | 0.19 | 0.14 |
| Weighted Avg Shares Out | 2,754 | 2,754 | 2,754 | 2,754 |
| Weighted Avg Shares Out Dil | 2,754 | 2,754 | 2,754 | 2,754 |
| Supplemental Information | – | – | – | – |
| Interest Income | $144 | $131 | $86 | $18 |
| Interest Expense | $11 | $5 | $2 | $2 |
| Depreciation & Amortization | $96 | $89 | $118 | $115 |
| EBITDA | $836 | $807 | $847 | $677 |
| % Margin | 9.8% | 10.1% | 11.3% | 9.6% |